Logo
Search for

Volume 19, Issue 1, Pages 44-49 (February 2010)


View previous. 12 of 17 View next.

Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger

Elke J.R. Lammersak, Paulien Huibersak, Maurice J.C. van der Sangenb, Lonneke V. van de Poll-Fransecd, Philip M.P. Poortmanse, Miranda F. Ernstf, Bea M.D. Lemaireg, Claartje M.E.M. Meijsh, Hans K.S. Nuytincki, Adri C. VoogdjCorresponding Author Informationemail address

Received 30 June 2009; received in revised form 12 September 2009; accepted 20 October 2009. published online 13 November 2009.

Abstract 

Long-term local control rates were studied in a series of 659 patients with invasive breast cancer aged 40 years or younger, who underwent mastectomy in general hospitals in the southern part of the Netherlands between 1988 and 2005. During a median follow-up time of 6.0 years, 34 patients developed a local recurrence in the chest wall without previous or simultaneous evidence of distant disease. The 5- and 10-year actuarial local recurrence rates for the total group were 5.6% (95% confidence interval [95% CI], 3.5–7.7%) and 7.3% (95% CI, 4.7–9.9%), respectively. A multivariate analysis showed that patients receiving radiotherapy (hazards ratio [HR], 0.29; 95% CI, 0.10–0.96) or adjuvant systemic treatment (HR 0.23; 95% CI, 0.08–0.65) had a significantly lower risk of local recurrence. It is concluded that excellent local control rates can be obtained with mastectomy in young women with breast cancer, especially in those who receive adjuvant systemic treatment and/or radiotherapy.

a Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands

b Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands

c Eindhoven Cancer Registry, Eindhoven, The Netherlands

d CoRPS – Centre of Research on Psychology in Somatic Diseases, Department of Medical Psychology, Tilburg University, The Netherlands

e Department of Radiotherapy, Bernard Verbeeten Institute, Tilburg, The Netherlands

f Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands

g Department of Surgery, Elkerliek Hospital, Helmond, The Netherlands

h Department of Surgery, St. Elisabeth Hospital, Tilburg, The Netherlands

i Department of Surgery, Amphia Hospital, Breda, The Netherlands

j Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW) Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands

Corresponding Author InformationCorresponding author. Tel.: +31 43 3882387; fax: +31 43 3884128.

k These authors contributed equally to this work.

PII: S0960-9776(09)00138-6

doi:10.1016/j.breast.2009.10.009


View previous. 12 of 17 View next.